Product Overview
Compound: PT‑141 (Bremelanotide) Nasal Spray
Format: Metered-dose nasal spray (~10 mg/mL)
Contents: 40 sprays per bottle (10 mg/spray)
Storage: Store at room temperature; refrigerate after opening.
For research/lab use only. Not for human administration.
Batch-specific third-party analysis ensures identity, purity, and stability. Email providers@theratideusa.com for your COA.
PT‑141 (Bremelanotide) is a cyclic heptapeptide agonist of melanocortin receptors (MC3R/MC4R) that works via central nervous system pathways rather than vascular mechanisms :contentReference[oaicite:1]{index=1}.
- Erectile Response: Intranasal PT‑141 enhanced erections, particularly when combined with sildenafil, with good tolerability in clinical trials :contentReference[oaicite:2]{index=2}.
- Onset & Tolerance: Effects appeared within 30–45 minutes, with common side effects of flushing, nausea, and transient blood pressure increase :contentReference[oaicite:3]{index=3}.
- FDA Approval: The subcutaneous formulation (Vyleesi) is approved (2019) for hypoactive sexual desire disorder (HSDD) in premenopausal women :contentReference[oaicite:4]{index=4}.
How quickly does the nasal spray work?
Typically within 30–45 minutes after use :contentReference[oaicite:5]{index=5}.
Is it safe?
Well-tolerated in clinical settings. Mild flushing and nausea are common; blood pressure should be monitored during research protocols :contentReference[oaicite:6]{index=6}.
Can it be used alone?
Yes—effective alone or in combination with PDE5 inhibitors, though combinations showed stronger responses :contentReference[oaicite:7]{index=7}.
Is this product FDA-approved?
The nasal spray form is not approved for human use. Only the injectable form (Vyleesi) is FDA-approved for women’s sexual health :contentReference[oaicite:8]{index=8}.
This product is sold for research purposes only and not intended for human use or as a dietary supplement. Please review our Terms & Conditions before ordering.
Safety Information: Keep out of reach of children. Use only with appropriate laboratory protocols.
FDA Notice: These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.